社区卫生工作者和糖尿病患者对高尿血和痛风的知识,态度和实践
Shiyi Sun1,2, Lihong Chen1,2, Dawei Chen1,2
1Department of Endocrinology & Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Healthcare (Basel, Switzerland)
|June 19, 2024
概括
社区卫生工作者对高尿血和痛风有适度的了解,但糖尿病患者的认识较低. 许多医疗保健提供者和患者缺乏对痛风管理和高尿血风险的了解.
科学领域:
- 内分泌学 在内分泌学.
- 类风湿病学 类风湿病学
- 公共卫生 公共卫生
背景情况:
- 超尿路血症在糖尿病患者中很常见,但经常被忽视.
- 痛风和高尿血需要更好的理解,以有效管理.
研究的目的:
- 评估有关高尿血和痛风的知识,态度和做法.
- 重点关注成都成华区社区卫生工作者和糖尿病患者.
主要方法:
- 使用问卷进行横截面研究.
- 调查了709名社区卫生工作者和508名糖尿病患者 (2021年8月 - 2022年1月).
主要成果:
- 社区卫生工作者知识中等 (17.74/30);对痛风治疗和药物禁忌的认识有限.
- 糖尿病患者的意识较低 (7.21/26);许多人错误地将高尿素血与痛风联系起来,并倾向于对急性发作进行非药物治疗.
结论:
- 医疗保健提供者和糖尿病患者之间存在关于高尿血和痛风的知识差距.
- 需要有针对性的教育干预措施来改善对这些疾病的理解和管理.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
522
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
522
Diabetes: Management and Pharmacotherapy
257
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
257
Oral Hypoglycemic Agents: Biguanides and Glitazones
188
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
188
Hypoglycemia and Glucagon
256
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
256
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K


